Kyleena 19.5 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FSKF7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,566
Award facts
- Contract value 100% obligated
- $6,565.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,565.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Kyleena 19.5 mg contraceptive systems. The award, issued on January 26, 2026, with an ultimate completion date of February 17, 2026, was made without set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and serve as the sole contractor on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a comprehensive $30.3 billion acquisition strategy designed to supply Department of Defense military healthcare facilities worldwide. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to procure a full range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's established performance history across numerous delivery orders for critical pharmaceutical products demonstrates its capability to support recurring medical supply needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FSKF7?
SPE2DR26FSKF7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FSKF7 worth?
The government has obligated $6,566 on SPE2DR26FSKF7.
Is contract SPE2DR26FSKF7 an order under another contract?
Yes. SPE2DR26FSKF7 is a delivery order under SPE2DR25D9317, an indefinite delivery contract.
Was contract SPE2DR26FSKF7 competed?
The extent of competition for SPE2DR26FSKF7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award